Month: May 2023

The Concept Elicitation Study Informed the Selection of the Primary, Secondary, and Exploratory Endpoints Included in the Phase 2b RESPOND Clinical Study Evaluating the Efficacy and Safety of Sildenafil Cream, 3.6% in Premenopausal Patients with Female Sexual Arousal Disorder Topline Data from the Exploratory Phase 2b RESPOND Study are Anticipated 2Q-2023 SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the publication of results of the patient-centered study designed to elucidate the commonly reported symptoms, including severity of symptoms, associated with female sexual arousal disorder (FSAD). The publication, “Symptoms and associated impact in pre-and postmenopausal women with sexual arousal disorder: a concept elicitation study,” appears...

AUSTIN, Texas, May 31, 2023 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, announced the online publication of three abstracts supporting the clinical utility of OvaWatchSM at the 2023 American Society of Clinical Oncology (ASCO) Meeting taking place in Chicago, Il on June 2-6, 2023. These abstracts were co-authored by the Aspira Women’s Health Innovation Team and Dr. Gerard Reilly, Director of Clinical Research and Innovation at Axia Women’s Health. The abstracts support the clinical efficacy of the newly released OvaWatch by confirming OvaWatch as an industry-leading ovarian cancer risk assessment test that can safely reduce premature surgeries in the management of adnexal masses. Reported...

SALT LAKE CITY, May 31, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has named Adam Brufsky, MD, PhD, FACP, as Scientific Advisor to its oncology business unit. In his new role, Dr. Brufsky is responsible for guiding clinical development and medical affairs to further elevate Myriad’s Precise™ Oncology Solutions portfolio. “Adam is an accomplished leader and respected expert in the field of medical oncology and brings a unique combination of academic, research and clinical experience to Myriad,” said Michael Lyons, general manager of oncology, Myriad Genetics. “He will play an instrumental role in advancing our long-term vision for growth and innovation in the oncology space.” Dr. Brufsky is Professor of Medicine at the University of...

SAN FRANCISCO, May 31, 2023 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, today announced that management will present at the Jefferies Healthcare Conference Wednesday, June 7, 2023, at 10:30 a.m. (ET) in New York, NY. A live webcast of the Company presentation will be available through the investor relations section of the Company’s website at www.akerotx.com. Following the live webcast, an archived replay will be available on the Company’s website. About Akero TherapeuticsAkero Therapeutics is a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including non-alcoholic steatohepatitis...

Company Announcement No. 24/2023  Copenhagen, 31 May 2023 Scandinavian Tobacco Group A/S completes the acquisition of the brand XQS. Effective 31 May 2023, Scandinavian Tobacco Group (the “Company”) has completed the acquisition of substantially all assets of the Swedish company XQS International AB (“XQS”). Reference is made to the Company’s announcement of 23 April 2023. For further information, please contact:Torben Sand, Head of IR & Communication, phone +45 5084 7222 or torben.sand@st-group.comEliza Dabbagh, IR and Communication, phone +45 5080 7619 or eliza.michael@st-group.comAttachmentCompany Announcement no 24 2023

SAN JOSE, Calif., May 31, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that three submitted abstracts were accepted for poster presentations at the 105th annual meeting of The Endocrine Society (ENDO 2023) taking place June 15-18, 2023, in Chicago, Illinois. The first of Rani’s abstracts noted below will be featured in a news conference hosted by the Endocrine Society from 9-10 am C.T. on June 17, 2023 in Room W-186B in McCormick Place’s West Building. Details of the abstracts being presented at ENDO are as follows: Abstract Title: An Orally Administered Robotic Pill (RP) Reliably and Safely Delivers the Human Parathyroid Hormone Analog hPTH (1-34) (Teriparatide)...

RADNOR, Pa., May 31, 2023 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone, today announced that its Chief Executive Officer Jon Congleton, and Chief Financial Officer and Chief Business Officer, Adam Levy, will be giving a presentation at the Jefferies Healthcare Conference in New York at 9:30 a.m. ET on Friday, June 9, 2023. The live webcast of the presentation can be accessed under “News and Events” on the Investor Relations section of the Mineralys website at www.mineralystx.com. A replay of the webcast will be available on the Company’s website for approximately 90 days. 2023 Jefferies Healthcare Conference:Date:  Friday, June 9, 2023Time: 9:30 a.m. ETWebcast Link  About Mineralys Mineralys...

AMSC Receives $5 Million 3 MW ECS Order and has Agreed to Provide nearly $15 Million in 2 MW ECS to Support Inox Wind’s Share of Surging Wind Market in India AYER, Mass., May 31, 2023 (GLOBE NEWSWIRE) — AMSC (NASDAQ: AMSC), a leading system provider of megawatt-scale power resiliency solutions that orchestrate the rhythm and harmony of power on the grid™, and protect and expand the capability of our Navy’s fleet, today announced it has agreed to deliver nearly $20 million of demand for its wind turbine electrical control systems (ECS) to Inox Wind Limited (Inox), including its 2-megawatt (MW) ECS and an order for its 3 MW ECS. AMSC expects to ship these systems over the course of fiscal year 2023. “Due in part to our strong and growing partnership with AMSC, Inox was among the first manufacturers to produce 2 MW and now...

SANTA CLARA, Calif., May 31, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today released its 2022 ESG Report highlighting accomplishments in environmental, social, and governance (ESG) across its global markets. “We are proud to release our ESG Report, which showcases our continued progress during 2022 towards developing a more sustainable business across our global business and to being a responsible corporate citizen that prioritizes our ethical values, inclusive culture and environmental initiatives,” said Doug Godshall, President and Chief Executive Officer, “The Corporate Values that drive us at Shockwave go beyond our patient-centric devices and extend to addressing the impact...

Unveils New Top Kontrol Marketing and Investor Awareness Initiative ROSEVILLE, Minn., May 31, 2023 (GLOBE NEWSWIRE) — SecureTech Innovations, Inc. (OTC: SCTH), an emerging growth company that develops and markets cutting-edge security and safety devices, products, and technologies such as Top Kontrol and its early-stage cybersecurity and cryptocurrency technology incubator Piranha Blockchain, announces it generated record Top Kontrol sales growth of 114% during the first quarter of 2023. Seeking to build upon this record sales growth, SecureTech announces it is launching a cross-marketing initiative aimed at growing product/brand awareness while converting existing and prospective shareholders into Top Kontrol customers. It’s a win-win for public safety and SecureTech’s shareholders. SecureTech’s President and CEO Kao Lee commented,...